Japan is poised to overhaul its cannabis legislation by criminalising recreational use while legalising medical use, a significant shift set to commence on December 12. This policy change introduces stringent penalties, including up to seven years’ imprisonment for recreational cannabis use, reflecting growing concerns over drug abuse among the youth. Currently, Japan does not penalise cannabis use to protect hemp farmers, but rising usage rates, particularly among teenagers and young adults, have prompted the government to act. In 2022, a record 6,482 cannabis-related investigations were conducted, marking a substantial increase from the previous year, with over 70% involving young people.

In a progressive move, Japan will also permit medical cannabis products, aligning with international trends where such medications are utilised to treat severe conditions like epilepsy. This development follows extensive governmental reviews from 2020 to 2023, focusing on the substance’s expanding medical applications and the need to curb recreational misuse. The updated law classifies cannabis as a narcotic under the Narcotics Control Act, imposing penalties for possession, use, and importation akin to those for other controlled substances. This dual approach aims to balance medical advancements with societal safety, marking a pivotal moment in Japan’s drug policy reform.

As Japan gets ready to put these new cannabis laws in place, it’s important to focus on educating young people about the risks of recreational use. The government and local communities should work together to raise awareness of these dangers while also sharing the benefits of medical cannabis. By promoting informed choices, Japan can handle this change in its drug policy more effectively.

Source: Forbes